Results 71 to 80 of about 62,792 (187)

Primary cutaneous mucinous carcinoma: A rare case report

Indian Journal of Dermatopathology and Diagnostic Dermatology, 2020
Primary cutaneous mucinous carcinoma is a rare slowly growing neoplasm showing predilection for the head and neck, particularly the eyelids. On occasion, it affects other sites including scalp, face, ear, axillae, thorax, abdomen, groin, foot, hand, and ...
K N Roopa, Meena N Jadhav, Shreekant K Kittur, Gajanan A Pise   +3 more
doaj   +1 more source

Pure and Mixed Mucinous Carcinoma of the Breast

European Journal of Breast Health, 2013
Objective: Mucinous carcinoma of the breast is relatively rare and the prevalence of its pure form among all carcinomas of the breast is 2%. Its pure and mixed types have been defined.
Ebubekir Gündeş, Faruk Aksoy, Celalettin Vatansev, Murat Çakır   +3 more
doaj   +1 more source

Determining the date of diagnosis – is it a simple matter? The impact of different approaches to dating diagnosis on estimates of delayed care for ovarian cancer in UK primary care [PDF]

, 2009
Background Studies of cancer incidence and early management will increasingly draw on routine electronic patient records. However, data may be incomplete or inaccurate.
A Majeed, A Rosemary Tate, A Verdecchia, AB Ryerson, Alexander GR Martin, B Rachet, B Yawn, BA Goff, BA Goff, BA Goff, CR Bankhead, F Berrino, Jackie A Cassell, JMJ Kirwan, K Sikora, M Richards, ML Wynn, MP Coleman, R Horton, R Jones, R Lawrenson, Sarah R Anderson, SW Pascoe, Tarita Murray-Thomas, VL Allgar, VL Allgar, W Hamilton, W Hamilton   +27 more
core   +3 more sources

Invasive Colloid Carcinoma and the role of Ki-67 and HER2 – Two case reports

Radiology Case Reports, 2019
Mucinous carcinoma (also termed colloid carcinoma) of the breast accounts for 1%-6% of all breast cancer and is considered to have a good relative prognosis.
Sarvanand Patel, BA, Shiv Bhanu, MD, Nishi Mehta, MD, Lauren Green, MD, Elise Saddleton, MD   +4 more
doaj  

Human epididymis protein 4 (HE4) in benign and malignant diseases [PDF]

, 2012
Background: Human epididymis protein 4 (HE4) is described as a useful new biomarker in ovarian cancer. As HE4 is neither tumor nor organ specific, we intensively investigated the occurrence of this protein in female and male patients with various benign ...
Anastasi, Anastasi, Andersen, Andersen, Bast, Bast, Drapkin, Drapkin, Duffy, Duffy, Escudero, Escudero, Galgano, Galgano, Heintz, Heintz, Hellstrom, Hellstrom, Hellstrom, Hellstrom, Holcomb, Holcomb, Huhtinen, Huhtinen, Jacob, Jacob, Jacobs, Jacobs, Kurman, Kurman, Liu, Liu, Montagnana, Montagnana, Moore, Moore, Nolen, Nolen, Tuxen, Tuxen   +39 more
core   +1 more source

Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments. [PDF]

, 2018
In this study we utilized data on patient responses to guided treatments, and we evaluated their benefit for a non-small cell lung cancer cohort. The recommended therapies used were predicted using tumor molecular profiles that involved a range of ...
Alifrangis, C, Belluz, LDB, Carter, P, Cereser, B, Chandrasinghe, P, Krell, J, Lim, E, Moderau, N, Poyia, F, Stebbing, J, Tabassum, N, Zhang, H   +11 more
core   +2 more sources

Duodenal Mucinous Carcinoma: A Case Report

대한영상의학회지, 2015
Duodenal mucinous carcinoma is exceedingly rare and a case report about duodenal mucinous carcinoma in a 61-year-old man mimicking pancreatic cystic neoplasm by radiological evaluation, endoscopy, and even surgical findings is presented.
Keum Nahn Jee
doaj   +1 more source

A cytomorphological study of secretions in breast cancer

Journal of Cytology, 2011
Background: Secretions are seen in a range of breast cancer that includes invasive ductal carcinoma, mucinous carcinoma and secretory carcinoma. Evaluation of the quantity and location of secretions and the contours of the cell clusters complement cell ...
Arati Bhatia, Geetu Malhotra, Punita Grover, Navjeevan Singh   +3 more
doaj   +1 more source

Biochemical markers in cancer of the ovary : a review [PDF]

, 1990
The ideal tumour marker would be one which is detectable before obvious clinical involvement. A number of biochemical markers have been used to diagnose carcinoma of the ovary.
Cauchi, Maurice N.
core  

Metachronous mucinous breast carcinoma and mucinous pancreatic cystadenoma in a patient with metabolic comorbidities; case report and a literature review

Journal of Mind and Medical Sciences
Mucinous breast carcinoma is a rare subtype of mammary neoplasm encountered in medical practice. It represents approximately 1-6% of all breast cancers and is more common in postmenopausal women.
Teodora Gabriela Alexescu, Irina Obada, Angela Cozma, Mirela Georgiana Perne, Olga Hilda Orășan, Vasile Negrean, Iacob Domșa, Victoria Ruta, Simina Felicia Țărmure   +8 more
doaj   +1 more source